Tau Therapeutics LLC and Xdynia LLC have merged into a combined company called Cavion LLC.

Both companies have been developing calcium-channel inhibitors for separate uses. Tau develops them to try to improve the efficacy of chemotherapy and radiation treatments in tumor cancers, while Xdynia focuses on the development to try to treat neuropathic pain and other neurologic diseases.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.